Abstract:Cardiac hypertrophy is characterized by an increase in cell size in the absence of cell division and is accompanied by a number of qualitative and quantitative changes in gene expression. Most forms of hypertrophy in vivo are compensatory or adaptative responses to increased workload resulting from various physiological and/or pathological etiologies. Until severe pathological alterations become apparent, myocytes show no drastic morphological changes. On the level of gene expression, upregulation of the so-called fetal genes, i.e., beta-myosin heavy chain, alpha-skeletal and alpha-smooth muscle actin, and atrial natriuretic factor (ANF) may be observed concomitant with a downregulation of alpha-myosin heavy chain and the Ca pump of sarcoplasmic reticulum. The use of primary cell culture systems for cardiomyocytes as an in vitro model for the hypertrophic reaction has identified a number of different stimuli as mediators of cardiac myocyte hypertrophy. The molecular dissection of the different intracellular signaling pathways involved herein has uncovered a number of branching points to cytosolic and nuclear targets and has identified many interactions between these pathways. The individual administration of these hypertrophic stimuli, i.e., hormones, cytokines, growth factors, vasoactive peptides, and catecholamines, to cultured cardiomyocytes, reveals that each stimulus induces a distinct phenotype as characterized by gene expression pattern and cellular morphology. Surprisingly, triiodothyronine (T3) and basic fibroblast growth factor (bFGF) effect a similar cellular phenotype although they use completely different intracellular pathways. This phenotype is characterized by drastic inhibition of myofibrillar growth and by upregulation of alpha-smooth muscle actin. On the other hand, insulin-like growth factor (IGF) I, a factor promoting muscle cell differentiation, and bFGF, an inhibitor of differentiation, cause completely different cardiomyocyte phenotypes although both are known to signal via receptor tyrosine kinases and have been shown to activate the Ras-Raf-MEK-MAP kinase pathway. However, both IGF-I and bFGF depend on T3 to bring about their typical responses, i.e., T3 is permissive for the action of these two growth factors on the expression of alpha-smooth muscle actin and cell morphology. Most of the hypertrophic stimuli are balanced under normal circumstances in vivo. When this balance is disturbed, however, a pathological heart phenotype may become dominant. Thus the knowledge of signaling pathways and cellular responses triggered by hypertrophic stimuli may be essential for the implementation of therapeutic strategies in the treatment of cardiac hypertrophy.

[Cardiocyte Hypertrophy Induced by Cultured Neonatal Rat Ventricular Fibroblast Conditioned Growth Medium].

The effect of chelerythrine on the hypertrophy of cardiac myocytes of neonatal rats induced by different glucose levels and its mechanism]

The Effect and Mechanism of -Blocker, Bisoprolol, on the Hypertrophy of Cardiomyocytes of Neonatal Rats Induced by High Glucose Levels

Reverse Effect of Protein Kinase C Inhibitor Ro-31-8220 on the Hypertrophy of Cardiomyocytes of Neonatal Rats Induced by High Glucose Levels

Effects of Fibroblast Growth Factor Inducible 14 (fn14) on High Glucose Induced-Cardiomyocyte Hypertrophy

Metoprolol and bisoprolol ameliorate hypertrophy of neonatal rat cardiomyocytes induced by high glucose via the PKC/NF-κB/c-fos signaling pathway.

Metoprolol and Bisoprolol Ameliorate Hypertrophy of Neonatal Rat Cardiomyocytes Induced by High Glucose Via the PKC/NF-B/c-fos Signaling Pathway (vol 19, Pg 871, 2020)

Cardiomyocyte Hypertrophy Induced by Cultured Rat Mesenchymal Stem Cells Conditioned Medium

[Influence of Various Glucose Levels on the Structure and Function of Cultured Neonatal Rats Cardiomyocytes].

Growth-promoting Effect of Platelet-Derived Growth Factor on Rat Cardiac Myocytes

Improvement of Primary Culture of Cardiac Myocytes in Neonatal Rat

GelMA Micropattern Enhances Cardiomyocyte Organization, Maturation, and Contraction Via Contact Guidance.

Protective effect of fibroblast growth factor 21 on cardiomyocyte hypertrophy induced by high glucose

Alleviation of Angiotensin Ⅱ-induced Ventricular Hypertrophy in Neonatal Rat Cardiomyocytes by Endogenous Intermedin

Crosstalk between angiotensin II and platelet derived growth factor-BB mediated signal pathways in cardiomyocytes

Inhibition of Endothelin Converting Enzyme-1 Activity or Expression Ameliorates Angiotensin Ii-Induced Myocardial Hypertrophy in Cultured Cardiomyocytes

The Calcineurin-Myocyte Enhancer Factor 2c Pathway Mediates Cardiac Hypertrophy Induced by Endoplasmic Reticulum Stress in Neonatal Rat Cardiomyocytes

Mechanical Stretch‐induced Hypertrophy of Neonatal Rat Ventricular Myocytes is Mediated by Β1‐integrin‐microtubule Signaling Pathways

Effect of Intermedin(1-53) on Angiotensin Ii-Induced Hypertrophy in Neonatal Rat Ventricular Myocytes

Various hypertrophic stimuli induce distinct phenotypes in cardiomyocytes

Effects of Dl-Praeruptorin A on Cultured Neonatal Rat Ventricular Cardiomyocytes with Hypertrophy Induced by Endothelin-1.